FDA Approves Soliris® (Eculizumab) for the Treatment of Patients with
Soliris Start Form. By completing your start form, you’re providing consent to alexion to collect your. • have an infection or fever.
FDA Approves Soliris® (Eculizumab) for the Treatment of Patients with
Web soliris® (eculizumab) is a continuous therapy. • patients with a disease called paroxysmal nocturnal hemoglobinuria (pnh). Patients with a disease called paroxysmal nocturnal hemoglobinuria (pnh). Web before you receive soliris, tell your doctor about all of your medical conditions, including if you: Discover if soliris is the right treatment option for your patients today. • are pregnant or plan to become pregnant. *due to privacy regulations we will not be able to respond via fax with the. Web enrollment in the soliris rems program and additional information are available by telephone: Your doctor will discuss the ongoing timeline with you. Select important safety information before you receive soliris,.
• are pregnant or plan to become pregnant. Web soliris® (eculizumab) is a continuous therapy. Web getting started with soliris. Discover if soliris is the right treatment option for your patients today. Adults and children with a disease. Counsel you about the risk of meningococcal infection; Ad learn about the soliris dosing regimen, including initiation instructions. By completing your start form, you’re providing consent to alexion to collect your. Start carrying the card today, and carry it with you at all. Patients with a disease called paroxysmal nocturnal hemoglobinuria (pnh). Give you information and a patient.